Outcomes
lens thickness
ADVERSE EVENTS, MYOPIA, CYCLOPLEGIA, ACD
Primary outcome measures were myopia progression as defined by axial length (AL) measured in non-cycloplegia and SER measured in cycloplegia. Secondary outcome measures included were adverse events and reactions (AE/AR), changes in choroidal thickness and ocular biometry (i.e., keratometry, anterior chamber depth (ACD), lens thickness, vitreous chamber depth) after one year of treatment.